======= MID1IP1 ======= == Gene Information == * **Official Symbol**: MID1IP1 * **Official Name**: MID1 interacting protein 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=58526|58526]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NPA3|Q9NPA3]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MID1IP1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MID1IP1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/300961|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Plays a role in the regulation of lipogenesis in liver. Up-regulates ACACA enzyme activity. Required for efficient lipid biosynthesis, including triacylglycerol, diacylglycerol and phospholipid. Involved in stabilization of microtubules (By similarity). {ECO:0000250}. |Spot 14| |positive regulation of ligase activity| |regulation of ligase activity| |carnitine shuttle| |fatty acid transmembrane transport| |positive regulation of fatty acid biosynthetic process| |negative regulation of microtubule depolymerization| |regulation of microtubule depolymerization| |positive regulation of fatty acid metabolic process| |intracellular lipid transport| |negative regulation of microtubule polymerization or depolymerization| |regulation of fatty acid biosynthetic process| |long-chain fatty acid transport| |negative regulation of protein depolymerization| |negative regulation of protein complex disassembly| |fatty acid transport| |positive regulation of lipid biosynthetic process| |regulation of microtubule polymerization or depolymerization| |regulation of protein depolymerization| |protein polymerization| |regulation of fatty acid metabolic process| |mitochondrial transmembrane transport| |regulation of protein complex disassembly| |carboxylic acid transmembrane transport| |organic acid transmembrane transport| |negative regulation of supramolecular fiber organization| |monocarboxylic acid transport| |positive regulation of small molecule metabolic process| |negative regulation of cytoskeleton organization| |positive regulation of lipid metabolic process| |microtubule cytoskeleton| |regulation of cellular ketone metabolic process| |regulation of lipid biosynthetic process| |regulation of microtubule cytoskeleton organization| |protein C-terminus binding| |mitochondrial transport| |regulation of microtubule-based process| |anion transmembrane transport| |organic acid transport| |carboxylic acid transport| |lipid transport| |microtubule| |lipid localization| |regulation of supramolecular fiber organization| |negative regulation of organelle organization| |regulation of lipid metabolic process| |regulation of small molecule metabolic process| |organic anion transport| |regulation of cytoskeleton organization| |anion transport| |negative regulation of cellular component organization| |cellular protein-containing complex assembly| |ion transmembrane transport| |identical protein binding| |lipid metabolic process| |transmembrane transport| |regulation of organelle organization| |ion transport| |positive regulation of catalytic activity| |intracellular transport| |protein-containing complex assembly| |positive regulation of molecular function| |establishment of localization in cell| |protein-containing complex subunit organization| |positive regulation of cellular biosynthetic process| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp463|Caffeine 2600μM R08 exp463]]|-2.2| |[[:results:exp34|Rotenone 20μM R00 exp34]]|-1.96| |[[:results:exp48|Mubritinib 0.2μM R01 exp48]]|-1.93| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|1.79| |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|1.82| |[[:results:exp220|BAY-598 4μM R05 exp220]]|1.84| |[[:results:exp84|UM0125461 0.74μM R02 exp84]]|2.35| |[[:results:exp79|Q15 2.7μM R02 exp79]]|2.37| ^Gene^Correlation^ |[[:human genes:a:acaca|ACACA]]|0.485| Global Fraction of Cell Lines Where Essential: 0/694 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/26| |bone|0/26| |breast|0/30| |central nervous system|0/49| |cervix|0/4| |colorectal|0/17| |esophagus|0/11| |fibroblast|0/1| |gastric|0/14| |kidney|0/18| |liver|0/19| |lung|0/72| |lymphocyte|0/16| |ovary|0/25| |pancreas|0/22| |peripheral nervous system|0/15| |plasma cell|0/12| |prostate|0/1| |skin|0/20| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/28| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 15263 * **Expression level (log2 read counts)**: 6.52 {{:chemogenomics:nalm6 dist.png?nolink |}}